5 Compliance Lessons From Novartis' FCPA Settlement
By Gary Giampetruzzi, Jonathan Stevens and Michael Mottweiler · July 13, 2020, 6:04 PM EDT
On June 25, the U.S. Department of Justice announced a pair of deferred prosecution agreements with one current and one former subsidiary of Swiss pharmaceutical giant Novartis AG to resolve criminal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login